Kevin Raidy is a senior managing director at Blue Owl Capital and head of Healthcare Opportunities. In this role, he oversees all private and public investment activity related to Healthcare Opportunities and serves on the fund’s investment committee.

Previously, Kevin was a founder and managing partner of Cowen Healthcare Investments, the predecessor to Blue Owl Healthcare Opportunities. Before that, he served as Cowen’s head of investment banking and earlier as co-head of Cowen’s Equity Capital Markets Group. He was also a managing director at Ramius LLC, where he was responsible for direct investments and convertible bonds. Kevin’s sell-side experience includes 10 years at Shipley Raidy Capital Partners, a boutique investment banking firm he co-founded.

Kevin is a member of the board of directors at NodThera Ltd., Neuron23, Aro Biopharmaceuticals, and Latigo Biotherapeutics. He is also a board observer at Delfi Diagnostics and Aktis Oncology.

He earned a Bachelor of Science in economics with a concentration in finance from the Wharton School of the University of Pennsylvania.